Therapeutic area intelligence for Pediatric Brain Tumors with 2 indexed intelligence signals across regulatory, clinical, competitive, and market developments.

Signals: 2
Catalysts: 0
Companies: 0

Companies

No related entities indexed yet.

Assets

memantine →

Recent signals(2)

ClinicalJuly 25, 2026

Memantine Pilot Study for Cognitive Protection in Pediatric Brain Tumor Patients Undergoing Radiation

A pilot study is underway to evaluate memantine as a neuro-protective agent in children receiving cranial radiation therapy for localized brain tumors.

ClinicalJune 30, 2026

Trial on Radiation Planning Aims to Reduce Neurocognitive Impairments in Pediatric Patients

A clinical trial is assessing whether targeted radiation planning can minimize cognitive impairments in pediatric patients undergoing treatment for brain tumors.

Upcoming catalysts

No catalysts indexed for this entity yet.

Indications

No related entities indexed yet.

Newsletter

Get signals before the market moves

Concise strategic intelligence on regulatory, clinical, competitive, and market developments — free to subscribe.

No paywall. No spam. Unsubscribe anytime.